Latest News for: boreas (journal)

Edit

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD

Pharmiweb 28 Mar 2025
Paris and Tarrytown, NY, March 28, 2025 ... The approval in Japan was based on data from the landmark BOREAS phase 3 study ... Results from BOREAS and the replicate NOTUS phase 3 study were published in The New England Journal of Medicine ... About COPD ... SNY ... .
  • 1
×